Journal of Cardiac Failure
Volume 16, Issue 5 , Pages 439-449 , May 2010

Gender Differences in Cardiac Dysfunction and Remodeling due to Volume Overload

  • Melissa R. Dent, MSc

      Affiliations

    • Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre and Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada
    • ,
  • Paramjit S. Tappia, PhD

      Affiliations

    • Department of Human Nutritional Sciences, Faculty of Human Ecology, University of Manitoba, Winnipeg, Canada
    • ,
  • Naranjan S. Dhalla, MD (Hon), PhD

      Affiliations

    • Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre and Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada
    • Corresponding Author InformationReprint requests: Dr. Naranjan S. Dhalla, Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre, 351 Tache Avenue, Winnipeg, Manitoba, Canada R2H 2A6. Tel: 204-235-3417; Fax: 204-237-0347.

Received 3 September 2009 ,Revised 6 December 2009 ,Accepted 21 December 2009.

References 

  1. Hasenfuss G. Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res. 1998;39:60–76
  2. Hunter JJ, Chien KR. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 1999;341:1276–1283
  3. Safar ME, Smulyan H. Hypertension in women. Am J Hypertens. 2004;17:82–87
  4. Regitz-Zagrosek V, Lehmkuhl E. Heart failure and its treatment in women: role of hypertension, diabetes and estrogen. Herz. 2005;30:356–367
  5. Bello N, Mosca L. Epidemiology of coronary heart disease in Women. Prog Cardiovasc Dis. 2004;4:287–295
  6. Hoppe BL, Hermann DD. Sex differences in the causes and natural history of heart failure. Curr Cardiol Rep. 2003;5:193–199
  7. Jessup M, Pina IL. Is it important to examine gender differences in the epidemiology and outcome of severe heart failure?. J Thor Cardiovasc Surg. 2004;127:1247–1252
  8. Stromberg A, Martensson J. Gender differences in patients with heart failure. Eur J Cardiovasc Nurs. 2003;2:7–18
  9. Schonfelder G. The biological impact of estrogens on gender differences in congestive heart failure. Cardiovasc Res. 2005;67:573–574
  10. Biondi-Zoccai GGL, Baldi A, Biasucci LM, Abbate A. Female gender, myocardial remodeling and cardiac failure: are women protected from increased myocardiocyte apoptosis?. Ital Heart J. 2004;5:498–504
  11. Douglas PS, Katz SE, Weinberg EO, Chen MH, Bishop SP, Lorell BH. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol. 1998;32:1118–1125
  12. Skavdahl M, Steenbergen C, Clark J, Myers P, Demianenko T, Mao L, et al. Estrogen receptor-β mediates male-female differences in the development of pressure overload hypertrophy. Am J Physiol Heart Circ Physiol. 2005;288:H469–H476
  13. Litwin SE, Katz SE, Litwin CM, Morgan JP, Douglas PS. Gender differences in postinfarction left ventricular remodeling. Cardiology. 1999;91:173–183
  14. Alyono D, Ring WS, Anderson MR, Anderson RW. Left ventricular adaptation to volume overload from large aortocaval fistula. Surgery. 1984;96:360–367
  15. Flaim SF, Minteer WJ, Nellis SH, Clark DP. Chronic arteriovenous shunt: evaluation of a model for heart failure in rat. Am J Physiol Heart Circ Physiol. 1979;236:H698–H704
  16. Flaim SF, Minteer WJ, Zelis R. Acute effects of arterio-venous shunt on cardiovascular hemodynamics in rat. Pflügers Arch. 1980;385:203–209
  17. Gerdes AM, Clark LC, Capasso JM. Regression of cardiac hypertrophy after closing an aortocaval fistula in rats. Am J Physiol Heart Circ Physiol. 1995;268:H2345–H2351
  18. Hatt PY, Rakusan K, Gastineau P, Laplace M, Cluzeaud F. Aorto-caval fistula in the rat. An experimental model of heart volume overloading. Basic Res Cardiol. 1980;75:105–108
  19. Huang M, Hester RL, Guyton AC. Hemodynamic changes in rats after opening an arteriovenous fistula. Am J Physiol Heart Circ Physiol. 1992;262:H846–H851
  20. Liu Z, Hilbelink DR, Crockett WB, Gerdes AM. Regional changes in hemodynamics and cardiac myocyte size in rats with aortocaval fistulas. 1. Developing and established hypertrophy. Circ Res. 1991;69:52–58
  21. Liu Z, Hilbelink DR, Gerdes AM. Regional changes in hemodynamics and cardiac myocyte size in rats with aortocaval fistulas. 2. Long-term effects. Circ Res. 1991;69:59–65
  22. Wang X, Ren B, Liu S, Sentex E, Tappia PS, Dhalla NS. Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat. J Appl Physiol. 2003;94:752–763
  23. Gardner JD, Brower GL, Janicki JS. Gender differences in cardiac remodeling secondary to volume overload. J Card Fail. 2002;8:101–107
  24. Brower GL, Gardner JD, Janicki JS. Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy. Mol Cell Biochem. 2003;251:89–95
  25. Brower GL, Janicki JS. Contribution of ventricular remodeling to pathogenesis of heart failure in rats. Am J Physiol Heart Circ Physiol. 2001;280:H674–H683
  26. Dent MR, Das S, Dhalla NS. Alterations in both death and survival signals for apoptosis in heart failure due to volume overload. J Mol Cell Cardiol. 2007;43:726–732
  27. Nekooeian AA, Pang CCY. Effects of estrogen on venous function in rats with chronic heart failure. Am J Physiol Heart Circ Physiol. 2000;278:H1941–H1947
  28. Yang XP, Liu YH, Rhaleb NE, Kurihara N, Kim HE, Carretero OA. Echocardiographic assessment of cardiac function in conscious and anesthetized mice. Am J Physiol. 1999;277:H1967–H1974
  29. Dent MR, Dhalla NS, Tappia PS. Phospholipase C gene expression, protein contents and activities in cardiac hypertrophy and heart failure due to volume overload. Am J Physiol Heart Circ Physiol. 2004;287:H719–H727
  30. Sethi R, Adameova A, Dhalla KS, Khan M, Elimban V, Dhalla NS. Modification of epinephrine-induced arrhythmias by N-acteyl-L-cysteine and vitamin E. J Cardiovasc Pharmacol Therap. 2009;14:134–142
  31. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in human left ventricle. J Clin Invest. 1975;56:56–64
  32. Rosano GM, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 1993;342:133–136
  33. Huang A, Sun D, Koller A, Kaley G. Gender difference in flow-induced dilation and regulation of shear stress: role of estrogen and nitric oxide. Am J Physiol Regulatory Integrative Comp Physiol. 1998;275:R1571–R1577
  34. Briest W, Homagk L, Rabler B, Ziegelhoffer-Mihalovicova B, Meier H, Tannapfel A, et al. Norepinephrine-induced changes in cardiac transforming growth factor-β isoforms expression pattern of female and male rats. Hypertens. 2004;44:410–418
  35. Dunlay SM, Weston SA, Redfield MM, Killian JM, Roger VL. Tumor necrosis factor-α and mortality in heart failure: a community study. Circulation. 2008;118:625–631
  36. Rosenkranz-Weiss P, Tomek RJ, Matthew J, Eghbali M. Gender-specific differences in expression of mRNAs for functional and structural proteins in rat ventricular myocardium. J Mol Cell Cardiol. 1994;26:261–270
  37. Modena MG, Molinari R, Muia N, Castelli A, Pala F, Rossi R. Double-blind randomized placebo-controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women. Am J Hypertens. 1999;12:1000–1008
  38. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. J Am Med Assoc. 2002;288:221–232
  39. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. J Am Med Assoc. 2007;297:1465–1477
  40. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340:1801–1811
  41. Nordmeyer J, Eder S, Mahmoodzadeh S, Martus P, Fielitz J, Bass J, et al. Upregulation of myocardial estrogen receptors in human aortic stenosis. Circulation. 2004;110:3270–3275
  42. Grohe C, Kahlert S, Lobbert K, Vetter H. Expression of oestrogen receptor α and β in rat heart: role of local oestrogen synthesis. J Endocrinol. 1998;156:R1–R7
  43. Mahmoodzadeh S, Eder S, Nordmeyer J, Ehler E, Huber O, Martus P, et al. Estrogen receptor α up-regulation and redistribution in human heart failure. FASEB J. 2006;20:926–934
  44. Donaldson C, Eder S, Baker C, Aronovitz MJ, Weiss AD, Hall-Porter M, et al. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. Circ Res. 2009;104:265–275
  45. Lind JM, Chiu C, Ingles J, Yeates L, Humphries SE, Heather AK, et al. Sex hormone receptor gene variation associated with phenotype in male hypertrophic cardiomyopathy patients. J Mol Cell Cardiol. 2008;45:217–222
  46. Gardner JD, Brower GL, Janicki JS. Effects of dietary phytoestrogens on cardiac remodeling secondary to chronic volume overload in female rats. J Appl Physiol. 2005;99:1378–1383
  47. Drolet MC, Lachance D, Plante E, Roussel E, Couet J, Arsenault M. Gender-related differences in left ventricular remodeling in chronic severe aortic valve regurgitation in rats. J Heart Valve Dis. 2006;15:345–351
  48. Patten RD, Pourati I, Aronovitz MJ, Alsheikh-Ali A, Eder S, Force T, et al. 17 β-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload. J Card Fail. 2008;14:245–253
  49. Cavasin MA, Sankey SS, Yu AL, Menon S, Yang XP. Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol. 2003;284:H1560–H1569
  50. van Eickels M, Grohe C, Cleutjens JP, Janssen BJ, Wellens HJ, Doevendans PA. 17 β-estradiol attenuates the development of pressure-overload hypertrophy. Circulation. 2001;104:1419–1423

 Supported by a grant from the Canadian Institutes of Health Research. The infrastructural support for this project was provided by the St. Boniface Hospital Research Foundation. MRD was a recipient of a Predoctoral Research Award from the Heart & Stroke Foundation of Canada.

PII: S1071-9164(09)01237-8

doi: 10.1016/j.cardfail.2009.12.017

Journal of Cardiac Failure
Volume 16, Issue 5 , Pages 439-449 , May 2010

Article Tools

* Image Usage & Resolution